Metis TechBio collaborates with Eli Lilly to develop innovative tissue-specific drug delivery technologies worth up to $1.1 ...
Merck KGaA announced its acquisition of Silence Therapeutics for $1.3 billion, enhancing its gene silencing strategies and ...
EyePoint Pharmaceuticals announces a drastic workforce reduction amidst ongoing struggles with its experimental drug, Duravyu ...
Disc Medicine's late-stage trial success reveals promising results for its experimental sun-allergy pill, bitopertin, ...
Sun Pharmaceutical Industries is set to raise 100 billion rupees ($1.05 billion) through five-year bonds, aimed at ...
The approved ANDA is therapeutically equivalent to Sandoz’s Ciprodex Otic Suspension, which has an estimated market of $110 million, according to IQVIA.
In its first phase, the facility will manufacture oral solid dosage forms for the Sri Lankan market and is projected to begun commercial operations in 2028.
Millions of cancer patients in India are forced into financial distress due to exorbitant drug prices. This article explores ...
Lupin Limited has gained CDSCO approval for a biosimilar version of nivolumab, an immunotherapy for cancer, joining other ...
The Indian government has mandated a 30% cap on trade margins for 137 cancer drugs, aiming to reduce prices and alleviate ...
India’s MedTech manufacturers have made steady progress in recent years, but further development of testing infrastructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results